Protalix and Chiesi Report Positive Results From Fabry Disease Trial Post author:PacConAdmin Post published:March 21, 2022 Post category:Drug Industry Daily The rare inherited condition Fabry Disease (FD) may soon have a new treatment. Source: Drug Industry Daily You Might Also Like PhRMA Blasts WHO Efforts to Pause Patent Rights for COVID-19 Medicines February 6, 2022 From Phones that Act Like Stethoscopes to VR Surgery, Device Innovations Abound June 9, 2023 FDA Sends Warning Letters to Three Drug Manufacturers April 13, 2022